Bovine lactoferrin counteracts Toll-Like receptor mediated activation signals in antigen presenting cells

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Puddu, Patrizia ^a   Latorre, Daniela ^a   Carollo, Maria ^a   Catizone, Angela ^b   Ricci, Giulia ^c   Valenti, Piera ^b   Gessani, Sandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CD83 ANTIGEN; CHEMOKINE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 2; INTERLEUKIN 6; LACTOFERRIN; PROGRAMMED DEATH 1 LIGAND 1; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; TOLL LIKE RECEPTOR; ANTIINFLAMMATORY AGENT; CD14 ANTIGEN; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; COW; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TRANSCRIPTION INITIATION; ACTIVE TRANSPORT; ANIMAL; BIOSYNTHESIS; CATTLE; CELL NUCLEUS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; SECRETION; T LYMPHOCYTE;

BOVINAE; FUNGI; MAMMALIA;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD14; CATTLE; CELL DIFFERENTIATION; CELL NUCLEUS; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-6; LACTOFERRIN; MONOCYTES; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 79960724573     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022504     Document Type: Article

References (57)

1. Legrand D, Pierce A, Elass E, Carpentier M, Mariller C, et al. (2008) Lactoferrin structure and functions. Adv Exp Med Biol 606: 163-194.
2. Legrand D, Elass E, Carpentier M, Mazurier J, (2005) Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 62: 2549-2559.
3. Ward PP, Paz E, Conneely OM, (2005) Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 62: 2540-2548.
4. Valenti P, Antonini G, (2005) Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 62: 2576-2587.
5. Puddu P, Valenti P, Gessani S, (2009) Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie 91: 11-18.
6. Gordon S, (2007) The macrophage: past, present and future. Eur J Immunol 37 (Suppl 1): S9-17.
7. Martinez FO, Sica A, Mantovani A, Locati M, (2008) Macrophage activation and polarization. Front Biosci 13: 453-461.
8. Banchereau J, Paczesny S, Blanco P, Bennett L, Pascual V, et al. (2003) Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann N Y Acad Sci 987: 180-187.
9. Steinman RM, (2003) Some interfaces of dendritic cell biology. Apmis 111: 675-697.
10. Macagno A, Napolitani G, Lanzavecchia A, Sallusto F, (2007) Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol 28: 227-233.
11. Gregori S, (2011) Dendritic cells in networks of immunological tolerance. Tissue Antigens 77: 89-99.
12. Gogolak P, Rethi B, Szatmari I, Lanyi A, Dezso B, et al. (2007) Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARgamma. Blood 109: 643-652.
13. Cernadas M, Lu J, Watts G, Brenner MB, (2009) CD1a expression defines an interleukin-12 producing population of human dendritic cells. Clin Exp Immunol 155: 523-533.
14. Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, et al. (1994) Lactoferrin is a lipid A-binding protein. Infect Immun 62: 2628-2632.
15. Na YJ, Han SB, Kang JS, Yoon YD, Park SK, et al. (2004) Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int Immunopharmacol 4: 1187-1199.
16. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR, (1993) Interleukin-10. Annu Rev Immunol 11: 165-190.
17. de la Rosa G, Yang D, Tewary P, Varadhachary A, Oppenheim JJ, (2008) Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J Immunol 180: 6868-6876.
18. Spadaro M, Caorsi C, Ceruti P, Varadhachary A, Forni G, et al. (2008) Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. Faseb J.
19. Groot F, Geijtenbeek TB, Sanders RW, Baldwin CE, Sanchez-Hernandez M, et al. (2005) Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J Virol 79: 3009-3015.
20. Elass-Rochard E, Roseanu A, Legrand D, Trif M, Salmon V, et al. (1995) Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem J 312 (Pt 3): 839-845.
21. Puddu P, Latorre D, Valenti P, Gessani S, (2010) Immunoregulatory role of lactoferrin-lipopolysaccharide interactions. Biometals 23: 387-397.
22. Hegde S, Pahne J, Smola-Hess S, (2004) Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. Faseb J 18: 1439-1441.
23. Park SJ, Nakagawa T, Kitamura H, Atsumi T, Kamon H, et al. (2004) IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 173: 3844-3854.
24. Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, et al. (2004) Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J Immunol 172: 464-474.
25. Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, et al. (2005) Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 11: 1314-1321.
26. Cheng F, Wang HW, Cuenca A, Huang M, Ghansah T, et al. (2003) A critical role for Stat3 signaling in immune tolerance. Immunity 19: 425-436.
27. Li Y, Chu N, Rostami A, Zhang GX, (2006) Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 177: 1679-1688.
28. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, et al. (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189: 1363-1372.
29. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921.
30. Wells AD, (2009) New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting. J Immunol 182: 7331-7341.
31. Beverly B, Kang SM, Lenardo MJ, Schwartz RH, (1992) Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 4: 661-671.
32. Anderson AE, Sayers BL, Haniffa MA, Swan DJ, Diboll J, et al. (2008) Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J Leukoc Biol 84: 124-133.
33. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC, (1999) Lipopolysaccharide can block the potential of monocytes to differentiate into dendritic cells. J Leukoc Biol 65: 232-240.
34. Rotta G, Edwards EW, Sangaletti S, Bennett C, Ronzoni S, et al. (2003) Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo. J Exp Med 198: 1253-1263.
35. Bartz H, Avalos NM, Baetz A, Heeg K, Dalpke AH, (2006) Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation. Blood 108: 4102-4108.
36. Xie J, Qian J, Wang S, Freeman ME 3rd, Epstein J, et al. (2003) Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38. J Immunol 171: 4792-4800.
37. Chang CC, Wright A, Punnonen J, (2000) Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J Immunol 165: 3584-3591.
38. Okazaki T, Honjo T, (2006) The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 27: 195-201.
39. Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, et al. (2003) Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 170: 1257-1266.
40. Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, et al. (1997) A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185: 1743-1751.
41. Frick JS, Grunebach F, Autenrieth IB, (2010) Immunomodulation by semi-mature dendritic cells: a novel role of Toll-like receptors and interleukin-6. Int J Med Microbiol 300: 19-24.
42. Dienz O, Rincon M, (2009) The effects of IL-6 on CD4 T cell responses. Clin Immunol 130: 27-33.
43. Ratta M, Fagnoni F, Curti A, Vescovini R, Sansoni P, et al. (2002) Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood 100: 230-237.
44. Lunz JG 3rd, Specht SM, Murase N, Isse K, Demetris AJ, (2007) Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology 46: 1946-1959.
45. Penco S, Pastorino S, Bianchi-Scarra G, Garre C, (1995) Lactoferrin down-modulates the activity of the granulocyte macrophage colony-stimulating factor promoter in interleukin-1 beta-stimulated cells. J Biol Chem 270: 12263-12268.
46. Elass-Rochard E, Legrand D, Salmon V, Roseanu A, Trif M, et al. (1998) Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun 66: 486-491.
47. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC, (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
48. Nakata T, Yasuda M, Fujita M, Kataoka H, Kiura K, et al. (2006) CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell Microbiol 8: 1899-1909.
49. Gessani S, Testa U, Varano B, Di Marzio P, Borghi P, et al. (1993) Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors. J Immunol 151: 3758-3766.
50. Gauzzi MC, Purificato C, Donato K, Jin Y, Wang L, et al. (2005) Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J Immunol 174: 270-276.
51. Del Corno M, Michienzi A, Masotti A, Da Sacco L, Bottazzo GF, et al. (2009) CC chemokine ligand 2 down-modulation by selected Toll-like receptor agonist combinations contributes to T helper 1 polarization in human dendritic cells. Blood 114: 796-806.
52. Puddu P, Carollo MG, Belardelli F, Valenti P, Gessani S, (2007) Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages. J Leukoc Biol 82: 347-353.
53. Dunn-Siegrist I, Leger O, Daubeuf B, Poitevin Y, Depis F, et al. (2007) Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1. J Biol Chem 282: 34817-34827.
54. Meng G, Rutz M, Schiemann M, Metzger J, Grabiec A, et al. (2004) Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest 113: 1473-1481.
55. Conti L, Cardone M, Varano B, Puddu P, Belardelli F, et al. (2008) Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes. Eur J Immunol 38: 750-762.
56. Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, et al. (2005) Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med 11: 1118-1124.
57. Gauzzi MC, Canini I, Eid P, Belardelli F, Gessani S, (2002) Loss of type I IFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells. J Immunol 169: 3038-3045.